Cancer Research Institute honors UCLA scientist for basic, tumor immunology discoveries
The Cancer Research Institute presented the William B. Coley Award to Antoni Ribas, MD, PhD.
The award — named after a bone surgeon and cancer researcher credited with using the first immunotherapy to save a patient with inoperable cancer in 1891 — recognizes a scientist for seminal discoveries in basic immunology or tumor immunology.
Ribas, professor of medicine at David Geffen School of Medicine at University of California, Los Angeles — was selected for his efforts leading the clinical program that demonstrated the effectiveness of checkpoint inhibitors, his development of stem cell-based adoptive cell therapies, and his research that helped identify biomarkers of response and acquired resistance to PD-1 blockade therapies.
Ribas also serves as director of UCLA Parker Institute for Cancer Immunotherapy Center and as a member of Broad Stem Cell Research Center at UCLA.